Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)
Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the... Continue Reading
In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were... Continue Reading
Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results... Continue Reading
Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF According to an article recently published in the Journal of the American Medical Association, patients with cirrhosis of... Continue Reading
Nexavar® Added to Treatment Guidelines for Liver Cancer The drug Nexavar® (sorafenib) has been added to the list of treatment options for patients with liver cancer who are not eligible for a liver transplant.... Continue Reading
Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival Researchers in Hong Kong have reported that screening patients with chronic hepatitis for liver cancer improves liver... Continue Reading
Nexavar® Improves Survival in Advanced Liver Cancer The targeted agent Nexavar (sorafenib) is associated with improved survival and doubling of the time to cancer progression for patients with advanced... Continue Reading
Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular... Continue Reading
Invasive Measures May Improve Outcome for Patients with Liver Cancer A recent study reveals that a combination of chemoembolization and radiofrequency ablation is more effective than either treatment alone... Continue Reading
Sutent® Active in Liver Cancer Sutent® (sunitinib) reduces the risk of cancer spread and the rate of cancer growth among patients with a form of liver cancer known as hepatocellular carcinoma. These... Continue Reading